Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Allergopharma GmbH & Co. KG

Overview

The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Allergy

Interventions

wasp venomBIOLOGICAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * History of wasp venom allergy, * Positive RAST to wasp venom, * Positive skin prick test to wasp venom Exclusion Criteria: * Serious chronic diseases

Locations (1)

Allergopharma GmbH & Co. KG

Reinbek, Germany

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.